Symbols

BLLN

BillionToOne·NASDAQ

--(--)

BLLN fundamentals

BLLN Q4 2025 Earnings

BillionToOne (BLLN) released its earnings on Mar 4, 2026: revenue was 96.05M (YoY --), beat estimates; EPS was 0.11 (YoY --), beat estimates.

Revenue / YoY

96.05M

EPS / YoY

0.11

Report date

Mar 4, 2026

BLLN Earnings Call Summary for Q4,2025

Record Q4 Growth: 113% YoY revenue to $96.1 million, driven by 47% test volume and ASP growth.
Rule of 100 Achievement: Full-year 2025 revenue up 100% with 13% EBITDA margin.
Gross Margin Expansion: 71.4% in Q4, up 14.3 percentage points YoY.
Landmark United Contract: In-network agreement to accelerate test adoption and ASPs.
2026 Guidance: $430-445 million revenue (41-46% growth) with continued profitability.
Oncology Innovation: Launch of PGx and CH add-ons, MolDX coverage submission for Northstar Response.

Earnings

EPS

Revenue

Revenue & Expenses

BLLN has released its 2025 Q4 earnings report, with revenue of 96.05M, reflecting a YoY change of 113.09%, and net profit of 5.98M, showing a YoY change of 152.08%. The Sankey diagram below clearly presents BLLN's revenue sources and cost distribution.

Key Indicators

BillionToOne (BLLN) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

BillionToOne (BLLN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

BillionToOne (BLLN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

BillionToOne (BLLN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown